| 摘要 |
The invention relates to medicine, and specifically to methods for treating autoimmune diseases such as human systemic lupus erythematosus. A method for treating human systemic lupus erythematosus, including medicinal therapy, distinguished in that the treatment is carried out using therapeutic sessions, each of which consists of two ten-day periods, wherein the first stage includes the parallel introduction of: intramuscular injections of preparations from a group of interferons of 500000-1000000 IU per day for ten days; and infusion therapy using preparations from a group of antiaggregants or detoxification preparations with a quantity of 200 ml for the first five days and autohemotherapy in the form of a mixture in a single syringe of autologous blood in a quantity of 2 ml and normal human immunoglobulin in a quantity of 1.5 ml for the next five days; the second period includes the parallel oral administration of interferon inducers in a daily dose quantity and conducting intravenous infusion therapy using hepatoprotectors. The therapeutic treatment sessions are conducted once every three months. The therapeutic sessions are conducted until the normalization of immunological and laboratory indicators and the improvement of the patient's clinical health. The technical result of the claimed treatment method consists in reducing the toxic effect, and body's lack of dependency on the medicinal agents, the lack of clinical and immunological signs of worsening of systemic lupus erythematosus, reducing the frequency of relapse, the onset of stable remission, full recovery of health and damaged organs, recovery of reproductive functions in women, and reducing dependency on cytostatics and glucocorticosteroids. |
